Parmax Pharma Ltd Share Price
As on 18 July 2026 at 06:22 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
72.57%
Over 6 Months
90.43%
Over 1 Year
45.02%
Over 3 Years
85.25%
Parmax Pharma Ltd Summary
Close ₹56.50
Open ₹56.50
High ₹56.50
Low ₹56.50
Volume 5,405
Net Turnover (in Cr) ₹0.03
52Wk High ₹56.50
52Wk Low ₹22.60
52Wk High / Low
22.60
56.50
Parmax Pharma Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹21.14
EPS (TTM) -
Book Value (BV) -18.33
Div. Yield -
P/E (TTM) -5.08
Price/Book Value -3.08
Delivery % 100 %
Face Value 10
Key Ratios
PE Ratio -
PB Ratio -9.45
EV to Sales 0.83
PEG Ratio -
ROA -36.60
ROE -
Debt-Equity -
Net Profit Margin -3.62
Operating Profit Margin 1.06
Parmax Pharma Ltd Financials
Profit and Loss
No data available
Balance Sheet
No data available
Cash Flow
No data available
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 28.24 | 11.10 | 15.46 | 18.31 | 26.29 |
| Total Expenses | 29.57 | 16.76 | 15.42 | 18.01 | 25.08 |
| Profit Before Tax | -2.40 | -5.66 | 0.05 | 0.30 | 1.21 |
| Profit After Tax | -2.09 | -5.75 | -0.10 | 0.14 | 0.75 |
| Operating Profit After Depreciation | -0.74 | -5.03 | 0.42 | 0.69 | 1.56 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 7.97 | 9.27 | 9.50 | 10.44 | 10.84 |
| Total Non Current Assets | 8.75 | 9.56 | 10.08 | 11.42 | 12.39 |
| Total Current Assets | 10 | 5.77 | 7.53 | 6.56 | 10.34 |
| Total Assets | 18.75 | 15.33 | 17.61 | 17.97 | 22.73 |
| Total Shareholder's Fund | -1.99 | 0.11 | 5.86 | 5.96 | 5.82 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -0.96 | -0.20 | 0.33 | 0.75 | 3.53 |
| Net Cash Used In Investing Activities | -0.70 | -1.59 | -0.94 | -1.53 | -3.15 |
| Net Cash Used In Financing Activities | 1.40 | 1.43 | -0.04 | -0.91 | 0.40 |
No data available
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 3.31 | 4.33 | 2.53 | 1.94 | 4.83 |
| Total Expenses | 4.86 | 4.52 | 4.12 | 2.19 | 5.39 |
| Profit Before Tax | -2.27 | -0.73 | -2.08 | -0.76 | -1.79 |
| Profit After Tax | -0.58 | -0.73 | -2.08 | -0.76 | -1.49 |
| Operating Profit after Depreciation | -1.52 | -0.18 | -1.58 | -0.24 | -0.66 |
Parmax Pharma Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 56.50
S2 56.50
S3 56.50
Pivot 56.50
R1 56.50
R2 56.50
R3 56.50
Moving Average
20 SMA 40.64
50 SMA 34.89
100 SMA 33.48
200 SMA 33.44
Parmax Pharma Ltd Corporate Actions
No available data
Parmax Pharma Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
Parmax Pharma Ltd Top Mutal Funds Invested
No data available
Parmax Pharma Ltd News
Parmax Pharma to conduct EGM
On 2 July 2026
09 Jun 2026, 03:54 pm
Parmax Pharma to hold board meeting
On 8 June 2026
04 Jun 2026, 09:59 am
Parmax Pharma revises board meeting date
To 2 June 2026
02 Jun 2026, 04:02 pm
Parmax Pharma revises board meeting date
To 2 June 2026
30 May 2026, 04:01 pm
Parmax Pharma to discuss results
On 30 May 2026
29 May 2026, 11:17 am
Parmax Pharma Ltd Stock Analysis
- Annual revenue for Parmax Pharma Ltd increased by 154.42% to ₹28.24 crore in FY 2025 from ₹11.10 crore in FY 2024.
- Annual Net Profit for Parmax Pharma Ltd decreased by 63.59% to ₹-2.09 crore in FY 2025 from ₹-5.75 crore in FY 2024.
- Promoter Shareholding in Parmax Pharma Ltd remains unchanged by 0.00% in the most recent quarter, from 30.80% in December 2025 to 30.80% in March 2026.
- Parmax Pharma Ltd delivered a 1-year return of 45.02% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
- Parmax Pharma Ltd share price moved up by 4.99% from its previous close of INR ₹56.50. The latest Parmax Pharma Ltd share price is INR ₹59.32.
- Parmax Pharma Ltd share price today has been at a low of 59.32 and a high of 59.32. Over the past 52 weeks, the Parmax Pharma Ltd share price has seen a low of 22.60 and a high of 59.32.
FAQ’s
What is the share price of Parmax Pharma Ltd today?
Parmax Pharma Ltd share price as on 18 Jul 2026 is ₹ 59.32
What is the Market Cap of Parmax Pharma Ltd?
The market cap of Parmax Pharma Ltd stock is ₹21.14 Cr.
What is the PE Ratio of Parmax Pharma Ltd?
The Price to Earnings (P/E) Ratio of Parmax Pharma Ltd is -
What is the PB Ratio of Parmax Pharma Ltd?
The Price to Book (P/B) Ratio of Parmax Pharma Ltd is -9.45
What is the 52 week high of Parmax Pharma Ltd Share Price?
The 52 week high of Parmax Pharma Ltd share price stands at ₹56.50
What is the 52 week low of Parmax Pharma Ltd Share Price?
The 52 week low of Parmax Pharma Ltd share price stands at ₹22.60
How can I buy shares of Parmax Pharma Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Parmax Pharma Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
